Skip to content

Comparison Of Visual Outcomes Between Customised Laser In-Situ Keratomileusis And Customised Photorefractive Keratectomy

Comparison Of Visual Outcomes Between Wavefront-Guided Laser In-Situ Keratomileusis And Wavefront-Guided Photorefractive Keratectomy â?? A Prospective Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/12/022228
Enrollment
90
Registered
2019-12-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H52- Disorders of refraction and accommodation

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Dr Linsa Kunjumon
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Candidate should have a myopia between (-1.5 to 10 D) and astigmatism up to (-4D). 2) With documented stability of refraction, as demonstrated by a change of less than or equal to 1 D of myopia and (-0.5 D) of astigmatism at least 12 months prior to the preoperative examination 3) Patients undergoing customized LASIK (Zyoptix Bausch & Lomb Teneo 317 laser) surgery 4) Candidates with corneal thickness of 500μ and less, Minimal corneal thickness of 470μ and above on Orbscan and calculated residual stromal bed of minimum 300μ for PRK.

Exclusion criteria

Exclusion criteria: 1. Patients undergoing Femto laser-based LASIK surgery. 2. Abnormalities of the cornea (e.g. Keratoconus or other corneal ectasia, thinning, edema, interstitial keratitis, extensive vascularization). 3. Uncontrolled external disease of the eye (e.g. Dry eye, atopy, blepharitis). 4. Previous history of vitreoretinal surgery or any other intra ocular and extra ocular surgery. 5. One eyed patient. 6. Uncontrolled connective tissue or autoimmune disease. 7. Orbital, lid or ocular anatomy that precludes function of the microkeratome. 8. Pregnant or nursing woman.

Design outcomes

Primary

MeasureTime frame
1.Uncorrected visual acuity (UCVA) 2.Best corrected visual acuity (BCVA) Timepoint: Preoperatively later 1 month and 3 months

Secondary

MeasureTime frame
1.Contrast sensitivity 2.Higher order aberrations (HOAs) Timepoint: Preoperatively later 1 month and 3 months

Countries

India

Contacts

Public ContactDr Linsa Kunjumon

Aravind Eye Hospital and Post Graduate Institute of Ophthalmology

drshivan@rediffmail.com9033312879

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026